key: cord-1007670-2rvxkbbs
authors: COSMA, Stefano; CAROSSO, Andrea R.; CUSATO, Jessica; BORELLA, Fulvio; CAROSSO, Marco; BOVETTI, Marialuisa; FILIPPINI, Claudia; D’AVOLIO, Antonio; GHISETTI, Valeria; DI PERRI, Giovanni; BENEDETTO, Chiara
title: COVID-19 and first trimester spontaneous abortion: a case-control study of 225 pregnant patients
date: 2020-10-08
journal: Am J Obstet Gynecol
DOI: 10.1016/j.ajog.2020.10.005
sha: d84198fb61f864ad219873a4af2e0f430bc9887f
doc_id: 1007670
cord_uid: 2rvxkbbs

Background The disease caused by the “severe acute respiratory syndrome coronavirus 2” (SARS-CoV-2) was named Coronavirus Disease 19 (COVID-19) and classified as a global public health emergency. The evidence related to the impact of COVID-19 on pregnancy are limited to the second and the third trimester of pregnancy, while data on the first trimester are scant. Many viral infections can be harmful to the fetus during the first trimester of pregnancy, and whether SARS-CoV-2 is one of them is still unknown. Objective(s) With this study we evaluated SARS-CoV-2 infection as a risk factor for early pregnancy loss in first trimester of pregnancy. Furthermore, COVID-19 course in the first trimester was assessed. Study design Between February 22 and May 21, 2020, we conducted a case-control study at S. Anna Hospital, Turin, among first trimester pregnant women, paired for last menstruation. The cumulative incidence of COVID-19 was compared between women with spontaneous abortion (case group, n=100) and those with ongoing pregnancy (control group, n=125). Current or past infection was determined by detection of SARS-CoV-2 from nasopharingeal swab and SARS-CoV-2 IgG/IgM antibodies in blood sample. Patient demographics, COVID-19-related symptoms, and the main risk factors for abortion were collected. Results Twenty-three of the 225 women (23/225, 10.2%) tested positive for COVID-19 infection. There was no difference in the cumulative incidence of COVID-19 between the cases (11/100, 11%) and the controls (12/125, 9.6%) (p=0.73). Logistic regression analysis confirmed that COVID-19 was not an independent predictor of early pregnancy loss (Odd Ratio 1.28, confidence interval 0.53-3.08). COVID-19 related symptoms in the first trimester were fever, anosmia, ageusia, cough, arthralgia and diarrhea; no pneumonia or Hospital admission due to COVID-19-related symptoms were recorded. No difference in the incidence of symptoms was noted between the two groups. Conclusion(s) SARS-CoV-2 infection during the first trimester of pregnancy does not appear to predispose to early pregnancy loss; its cumulative incidence did not differ between women with spontaneous abortion and women with ongoing pregnancy. COVID-19 appears to have a favorable maternal course at the beginning of pregnancy, consistent with what has been observed during the second and the third trimester.

Despite the rapidly growing number of cases worldwide, data on COVID-19 during pregnancy remain limited, being 133 derived mainly from small sample studies. 3-8 A systematic review of published reports on coronaviruses (COVID-19, 134 SARS, MERS) reported higher rates of preterm birth, preeclampsia, cesarean section, and perinatal death. 9 The lack of 135 data on spontaneous abortion due to COVID-19 during the first trimester precludes extrapolation of conclusive evidence 136 for the effects of infection during early pregnancy. The paucity of reliable data has aroused concern in patients, while The wide of clinical expression, the high rate of asymptomatic forms, the poor accuracy of nasopharyngeal swab testing 140 and its limited availability have been the main barriers to gaining a real understanding of the prevalence of the infection 141 and its impact on pregnancy. In this complex scenario, the development of serological tests for the detection of SARS-142 CoV-2 IgG and IgM could be useful to identify pregnant patients who were infected during early pregnancy. While the 143 quantity and quality of data on test performance are still limited, the level of accuracy has been reportedly 144 moderate/good, so that patients infected by SARS-CoV-2 can be traced. 11

The aim of the present study was to evaluate the impact of COVID-19 on first trimester pregnancy loss by comparing 146 the cumulative incidence of SARS-CoV-2 infection in a cohort of women who experienced early spontaneous abortion 147 and that of women with ongoing pregnancy at 12 weeks of gestational age. Furthermore, COVID-19 course in the first 148 trimester was evaluated.

Women who had been referred to our Hospital for pregnancy loss care during the first 13 weeks of pregnancy, between 152 February 22 and May 21, 2020 were contacted and enrolled (case group). All women who had access to our emergency 153 room or to the pregnancy loss management service were contacted after being traced through our hospital's database. 

A total of 225 women at first trimester of pregnancy, attending our Institute were included in the study. One hundred 196 women in the case group and 125 women in the control group were enrolled. The patient attendance rate was 87% 197 (100/115) and 88% (125/142), respectively. Table 1 reports the patients' characteristics at baseline; except for age, there 198 were no statistically significant differences in demographics or risk factors for abortion between the two groups. Hospital admission due to COVID-19-related symptoms was recorded. No difference in the incidence of symptoms was 220 noted between the case (4/11, 36.4%) and the control group (8/12, 66.6%) (p=0.14). 

Another limitation is that patients with very early pregnancy loss may not have been enrolled in our study because they 290 did not require obstetric care, which is performed before the patient has her first obstetric visit. We believe, however, 291 that there is no reason to think that within this small patient group the cumulative incidence of COVID-19 would have 292 been so high as to question our results. It is difficult to hypothesize that "pre-clinical" abortions could be caused by 293 SARS-CoV-2 in a stage when pregnancy loss is much more likely to occur due to chromosomal defects in the embryo COVID-19 outbreak cases in Piedmont Region: weekly case increase

Coronaviruses: an overview of their replication and pathogenesis

Pre-labor anorectal swab for SARS-CoV-2 in COVID-19 patients: is it time 350 to think about it?

Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her 353 Newborn

Vaginal delivery in COVID-19 pregnant women: anorectum as a potential 355 alternative route of SARS-CoV-2 transmission

COVID-19 and ART: the view of the Italian Society of Fertility and 358 Sterility and Reproductive Medicine

Trimester Miscarriage in a Pregnant Woman With SARS-CoV

Visualization of SARS-CoV-2 virus invading the human placenta 377 using electron microscopy

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in 379

China: a retrospective cohort study

Placental Pathology in COVID-19

Analysis of Maternal Coronavirus Infections and Neonates Born 384 to Mothers with 2019-nCoV; a Systematic Review

COVID-19 Antibody Testing in Pregnancy

Screening all pregnant women admitted to labor and delivery for the 388 virus responsible for coronavirus disease 2019

Obesity could shift severe COVID-19 disease to younger ages

Antibody responses to SARS-CoV-2 in patients with COVID-19

First trimester pregnancy loss: Clinical implications of genetic testing

Spontaneous abortion and recurrent miscarriage: A 397 comparison of cytogenetic diagnosis in 250 cases

Association between different morphological types and 400 abnormal karyotypes in early pregnancy loss

Does the human placenta express the canonical cell entry mediators for 403 SARS-CoV-2? Elife

Coronavirus disease 2019 (COVID-19) and pregnancy: a systematic review

We thank the staff of the Laboratory of S. Anna Hospital for sample collection and storage. 316 317